Conferences
Conferences
Advertisement
Cecilia BrownBreast Cancer | October 14, 2024
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
Read More
Cecilia BrownBreast Cancer | October 10, 2024
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPTreatment | October 9, 2024
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
Emilie Plantamura, PharmD, PhDGVHD | October 8, 2024
The ongoing trial is evaluating if MaaT033 can increase survival by preventing complications such as GVHD.
Narjust Florez, MD, FASCOLung Cancer | October 7, 2024
Narjust Florez, MD, FASCO, discusses key considerations for oncology nurses caring for these patients.
Cecilia BrownBreast Cancer | October 4, 2024
Learn what the study showed about shorter courses of post-mastectomy radiation combined with breast reconstruction.
Cecilia BrownMPN | October 3, 2024
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
Cecilia BrownMultiple Myeloma | October 2, 2024
New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma.
Cecilia BrownGU Cancer | September 27, 2024
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
Cecilia BrownGU Cancer | September 25, 2024
Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer.
Bereket Abraha Molla, MDConferences | September 20, 2024
Researchers evaluated the renal status of more than 250 patients receiving TKIs in a chronic myeloid leukemia clinic.
Scott D. Goldfarb, PharmD, MSConferences | September 19, 2024
Researchers presented the results of the observational study at the 2024 SOHO Meeting.
Mamtha Balla, MD, MPH, FACP, FAPCRConferences | September 18, 2024
Research presented at the Annual Meeting of the Society of Hematologic Oncology provided insights on outcomes and risks.
Cecilia BrownConferences | September 13, 2024
An analysis of the RESPONSE and RESPONSE-2 studies further supports the benefit of ruxolitinib in these patients.
Prithviraj Bose, MDConferences | September 13, 2024
Dr. Bose shared his insights at the Twelfth Annual Society of Hematologic Oncology Meeting in Houston.
Cancer Nursing Today EditorsGVHD | September 10, 2024
A new study highlights the importance of effective management and close monitoring of GVHD.
Cancer Nursing Today EditorsHematology & Blood Cancer | October 2, 2024
A study of more than 10,000 patients illuminated the characteristics and needs of patients who are in remission.
Cancer Nursing Today EditorsMultiple Myeloma | September 6, 2024
Learn how an innovative rehabilitation model improved clinical outcomes and patient satisfaction with nursing care.
Cancer Nursing Today EditorsMultiple Myeloma | September 5, 2024
Learn about the diverse unmet needs and potential solutions related to the experiences of patients and caregivers.
Cancer Nursing Today EditorsConferences | September 4, 2024
New research shows that major depressive disorder is associated with certain outcomes in this population of patients.
Advertisement
Advertisement
Advertisement